抗菌薬耐性サーベイランス市場：コンポーネント別、エンドユーザー別-2024-2030年の世界予測

抗菌薬耐性サーベイランス市場規模は2023年に56億米ドルと推計され、2024年には59億6,000万米ドルに達し、CAGR 6.49％で2030年には87億1,000万米ドルに達すると予測されます。

抗菌薬耐性サーベイランス市場には、抗生物質、抗ウイルス剤、抗真菌剤、その他の抗菌剤に対して耐性を獲得する微生物の蔓延を監視、分析、制御する製品が含まれます。抗菌薬耐性サーベイランスの主な用途は、病院、地域保健センター、食品生産施設、畜産作業、水処理プラント、環境サンプルなど、さまざまな環境における耐性病原体の蔓延に関する情報を提供することです。世界中で多剤耐性菌が増加しているため、既存の治療法を適切に適応させるために常に監視する必要があります。分子診断技術の進歩は、抗生物質耐性株の早期発見と同定を可能にしています。さらに、ヘルスケア専門家の間で抗生物質管理プログラムに対する意識が高まっていることも、慎重な処方を促しています。成長の見通しにもかかわらず、いくつかの課題が抗菌薬耐性サーベイランス市場の進展を妨げています。中低所得国ではインフラや資金が不十分なため、サーベイランス能力が限られています。世界中で採用されている調査手法のばらつきが、地域間の結果の比較可能性を妨げています。しかし、ポイントオブケア検査機器の出現は診断を迅速化し、個別化された治療決定を可能にします。ゲノムシーケンス技術を活用することで、集団レベルでの耐性メカニズムや感染動態を正確に追跡することができます。これらに加え、事業の成長を維持し、世界の健康保障に貢献するために、利害関係者は、より迅速な発見のための診断ツールの改良、従来にない治療アプローチの探求、予測モデリングのための人工知能の活用といった主要分野に注力すべきです。

コンポーネント特定の耐性マーカーを比較的低コストで迅速に検出する診断キットの役割が大きい

抗菌薬耐性（AMR）サーベイランス市場は、薬剤耐性病原体の特定と管理に役立つ様々なコンポーネントで構成されています。診断キットは、病原菌の抗菌薬耐性を正確かつ迅速に検出し、適切な抗生物質療法によるタイムリーな介入を可能にするために不可欠です。これらのキットは、ポリメラーゼ連鎖反応（PCR）、酵素結合免疫吸着測定法（ELISA）、次世代シークエンシング（NGS）など、微生物の耐性遺伝子を同定するためのさまざまな技術を採用しています。診断システムには、AMR検出のためのハイスループット・スクリーニングや高度なデータ解析を容易にするラボベースの機器が含まれます。AMRサーベイランスサービスには、迅速感受性試験、全ゲノムシークエンシング、バイオインフォマティクス解析を提供する受託研究機関（CRO）やラボが含まれます。これらのサービスにより、ヘルスケアプロバイダーは、高価な機器や専門家に投資することなく、耐性病原体を検出するための最先端の技術や専門知識を利用することができます。データ管理ソフトウェアは、AMRサーベイランス中に生成される膨大な情報の集計、分析、解釈に重要な役割を果たします。

エンドユーザー：院内感染の増加により、次世代抗菌薬耐性（AMR）サーベイランスの必要性が高まる

抗菌薬耐性（AMR）との闘いにおいて、病院や研究・学術機関は重要な役割を担っており、それぞれのニーズに対応したサーベイランスシステムが必要とされています。病院は、臨床医が適切な抗生物質治療を提供し、耐性感染の拡大を防ぐための指針となる迅速診断ソリューションを優先します。研究・学術機関は、抗菌薬耐性メカニズムの解明、新規治療アプローチの開発、医療従事者の責任ある抗生物質使用の促進に重点を置いています。

地域別インサイト

抗菌薬耐性（AMR）は、南北アメリカと欧州全域で公衆衛生上の重大な脅威として浮上しています。AMRの継続的なサーベイランスは、ヘルスケアシステムへの影響の拡大を理解し、政策決定を導き、耐性感染に関連するリスクを軽減する効果的な戦略を実施する上で極めて重要です。南北アメリカと欧州におけるAMRレベル上昇の主な原動力となっているのは、ヒト医療、獣医診療、農業、食品生産部門における抗菌薬の過剰使用と誤用です。南北アメリカおよび欧州の先進諸国では、厳格な規制の枠組みが抗菌薬メーカーや抗菌薬提供者の行動を統制しています。急速な経済成長、ヘルスケア支出の増加、有利な政府政策などの要因により、AMRへの対応における新興国の可能性は計り知れないです。インド、中国、ブラジルのような新興国は、この問題に対処するため、抗菌薬耐性サーベイランスの研究開発に多額の投資を行い、官民パートナーシップを推進しています。各国政府は、抗菌薬耐性に対処するための技術革新にインセンティブを与えるため、研究開発（R&D）の取り組みに財政的支援を提供しています。例えば、2023年8月、英国政府は、抗菌薬耐性（AMR）サーベイランスの重要な側面である薬剤耐性菌の世界的サーベイランスを強化するために、2億1,000万ポンドという多額の投資を行った。しかし、この脅威と効果的に闘うためには、監視システムの強化、規制監督の改善、研究への投資、新たな治療法の開発に焦点を当てた取り組みが不可欠です。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは抗菌薬耐性サーベイランス市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、抗菌薬耐性サーベイランス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.抗菌薬耐性サーベイランス市場の市場規模および予測は？

2.抗菌薬耐性サーベイランス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.抗菌薬耐性サーベイランス市場の技術動向と規制枠組みは？

4.抗菌薬耐性サーベイランス市場における主要ベンダーの市場シェアは？

5.抗菌薬耐性サーベイランス市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 病原体による感染症の蔓延の増加
    • 診断とポイントオブケア診断の質を向上させる政府の取り組みが増加
  • 抑制要因
    • 抗菌薬耐性サーベイランスに関連する高コスト
  • 機会
    • 抗菌薬耐性（AMR）感染症を管理するための高度な診断ソリューションに対する需要の高まり
    • 世界中で診断製品の規制承認が増加
  • 課題
    • AMR監視のための標準化された方法とガイドラインの欠如
• 市場セグメンテーション分析
  • 構成要素：比較的低コストで特定の耐性マーカーを迅速に検出する診断キットの重要な役割
  • エンドユーザー：院内感染の発生率の増加により、次世代の抗菌薬耐性（AMR）監視の必要性が高まっています。
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 抗菌薬耐性サーベイランス市場：コンポーネント別

• 診断キット
• 診断システム
• サービス
• ソフトウェア

第7章 抗菌薬耐性サーベイランス市場：エンドユーザー別

• 病院
• 調査・学術機関

第8章 南北アメリカの抗菌薬耐性サーベイランス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の抗菌薬耐性サーベイランス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの抗菌薬耐性サーベイランス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • ノボ・ホールディングス、パラテック・ファーマシューティカルズの買収で抗菌薬耐性戦略を推進
  • AMRアクション基金、抗生物質耐性と闘うためのさらなる投資を発表
• 戦略分析と提言

第12章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET RESEARCH PROCESS
• FIGURE 2. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET DYNAMICS
• FIGURE 7. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 20. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY DIAGNOSTIC SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY DIAGNOSTIC SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 24. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 25. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 26. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 27. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 28. AMERICAS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 29. ARGENTINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 30. ARGENTINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 31. ARGENTINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 32. ARGENTINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 33. BRAZIL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 34. BRAZIL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 35. BRAZIL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 36. BRAZIL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 37. CANADA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 38. CANADA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 39. CANADA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 40. CANADA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 41. MEXICO ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 42. MEXICO ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 43. MEXICO ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 44. MEXICO ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 45. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 46. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 47. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 48. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 49. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 50. UNITED STATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 52. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 54. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 56. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 57. AUSTRALIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 58. AUSTRALIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 59. AUSTRALIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 60. AUSTRALIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 61. CHINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 62. CHINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 63. CHINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 64. CHINA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 65. INDIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 66. INDIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 67. INDIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 68. INDIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 69. INDONESIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 70. INDONESIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 71. INDONESIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 72. INDONESIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 73. JAPAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 74. JAPAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 75. JAPAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 76. JAPAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 77. MALAYSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 78. MALAYSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 79. MALAYSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 80. MALAYSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 81. PHILIPPINES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 82. PHILIPPINES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 83. PHILIPPINES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 84. PHILIPPINES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 85. SINGAPORE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 86. SINGAPORE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 87. SINGAPORE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 88. SINGAPORE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 90. SOUTH KOREA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 92. SOUTH KOREA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 93. TAIWAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 94. TAIWAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 95. TAIWAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 96. TAIWAN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 97. THAILAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 98. THAILAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 99. THAILAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 100. THAILAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 101. VIETNAM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 102. VIETNAM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 103. VIETNAM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 104. VIETNAM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 111. DENMARK ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 112. DENMARK ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 113. DENMARK ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 114. DENMARK ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 115. EGYPT ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 116. EGYPT ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 117. EGYPT ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 118. EGYPT ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 119. FINLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 120. FINLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 121. FINLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 122. FINLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 123. FRANCE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 124. FRANCE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 125. FRANCE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 126. FRANCE ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 127. GERMANY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 128. GERMANY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 129. GERMANY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 130. GERMANY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 131. ISRAEL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 132. ISRAEL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 133. ISRAEL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 134. ISRAEL ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 135. ITALY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 136. ITALY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 137. ITALY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 138. ITALY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 139. NETHERLANDS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 140. NETHERLANDS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 141. NETHERLANDS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 142. NETHERLANDS ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 143. NIGERIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 144. NIGERIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 145. NIGERIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 146. NIGERIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 147. NORWAY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 148. NORWAY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 149. NORWAY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 150. NORWAY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 151. POLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 152. POLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 153. POLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 154. POLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 155. QATAR ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 156. QATAR ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 157. QATAR ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 158. QATAR ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 159. RUSSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 160. RUSSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 161. RUSSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 162. RUSSIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 164. SAUDI ARABIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 166. SAUDI ARABIA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 168. SOUTH AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 170. SOUTH AFRICA ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 171. SPAIN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 172. SPAIN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 173. SPAIN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 174. SPAIN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 175. SWEDEN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 176. SWEDEN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 177. SWEDEN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 178. SWEDEN ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 179. SWITZERLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 180. SWITZERLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 181. SWITZERLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 182. SWITZERLAND ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 183. TURKEY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 184. TURKEY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 185. TURKEY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 186. TURKEY ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 192. UNITED KINGDOM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 194. UNITED KINGDOM ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 195. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. ANTIMICROBIAL RESISTANCE SURVEILLANCE MARKET, FPNV POSITIONING MATRIX, 2023

[196 Pages Report] The Antimicrobial Resistance Surveillance Market size was estimated at USD 5.60 billion in 2023 and expected to reach USD 5.96 billion in 2024, at a CAGR 6.49% to reach USD 8.71 billion by 2030.

The antimicrobial resistance surveillance market encompasses products to monitor, analyze, and control the spread of microorganisms that develop resistance to antibiotics, antivirals, antifungals, and other antimicrobial agents. The primary application of antimicrobial resistance surveillance is to provide information on the prevalence of resistant pathogens in various settings such as hospitals, community health centers, food production facilities, animal husbandry operations, water treatment plants, and environmental samples. The increasing prevalence of multidrug-resistant organisms worldwide necessitates constant monitoring to adapt existing treatments appropriately. Advances in molecular diagnostics techniques enable early detection and identification of antibiotic-resistant strains. Addtionally, growing awareness about antibiotic stewardship programs among healthcare professionals encourages prudent prescribing practices. Despite the growth prospects, several challenges hinder the antimicrobial resistance surveillance market progress. Inadequate infrastructure and funding in low and middle-income countries result in limited surveillance capabilities. Variability in laboratory methodologies employed worldwide hampers comparability of results across regions. However, the emergence of point-of-care testing devices expedites diagnosis and enables personalized treatment decisions. Harnessing genomic sequencing technologies allows for accurate tracking of resistance mechanisms and transmission dynamics at a population level. Along with these, to sustain business growth and contribute to global health security, stakeholders should focus on key areas like refining diagnostic tools for faster detection, exploring unconventional treatment approaches, utilizing artificial intelligence for predictive modeling.

Component: Significant role of diagnostic kits in offering rapid detection of specific resistance markers at relatively lower costs

The antimicrobial resistance (AMR) surveillance market comprises various components that help identify and manage drug-resistant pathogens. Diagnostic kits are essential for accurate and rapid detection of antimicrobial resistance in pathogens, enabling timely intervention with appropriate antibiotic therapy. These kits employ various techniques such as polymerase chain reaction (PCR), enzyme-linked immunosorbent assays (ELISA), and next-generation sequencing (NGS) to identify resistant genes in microorganisms. Diagnostic systems encompass laboratory-based instruments that facilitate high-throughput screening and advanced data analysis for AMR detection. AMR surveillance services include contract research organizations (CROs) and laboratories that provide accelerated susceptibility testing, whole-genome sequencing, and bioinformatics analysis. These services enable healthcare providers to access cutting-edge technology and expertise for detecting resistant pathogens without investing in expensive equipment or specialists. Data management software plays a crucial role in compiling, analyzing, and interpreting the vast amount of information generated during AMR surveillance.

End-User: Increasing incidence of hospital-acquired infections developed necessities for next generation antimicrobial resistance (AMR) surveillance

In the fight against antimicrobial resistance (AMR), hospitals and research & academic institutes play critical roles, necessitating tailored surveillance systems to address their distinct needs. Hospitals prioritize rapid diagnostic solutions that guide clinicians in providing appropriate antibiotic treatments and preventing the spread of resistant infections. Research & academic institutes focus on understanding antimicrobial resistance mechanisms, developing novel therapeutic approaches, and promoting responsible antibiotic use among healthcare professionals.

Regional Insights

Antimicrobial resistance (AMR) has emerged as a significant public health threat across the Americas and Europe. Continuous surveillance of AMR is crucial in understanding the growing impact on healthcare systems, guiding policy decisions, and implementing effective strategies to mitigate the risks associated with resistant infections. The major driving factors behind increased AMR levels in the Americas and Europe include the overuse and misuse of antimicrobials in human medicine, veterinary practice, agriculture, and food production sectors. In developed countries across the Americas and Europe, stringent regulatory frameworks govern the actions of manufacturers and providers of antimicrobial products. The potential associated with emerging countries in addressing AMR is immense due to factors such as rapid economic growth, increasing healthcare expenditure, and favorable government policies. Emerging economies like India, China, and Brazil are investing heavily in R&D for antimicrobial resistance surveillance and promoting public-private partnerships to address the issue. Governments provide financial support for research and development (R&D) efforts to incentivize innovation in addressing antimicrobial resistance. For instance, in August 2023, the UK government made a significant investment of £210 million to enhance global surveillance of drug-resistant bacteria, a critical aspect of Antimicrobial Resistance (AMR) surveillance. However, initiatives focusing on surveillance systems enhancement, regulatory oversight improvements, investment in research, and development of new treatments are crucial to combating this threat effectively.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antimicrobial Resistance Surveillance Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antimicrobial Resistance Surveillance Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Resistance Surveillance Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Becton, Dickinson and Company, bioMerieux SA, Cepheid, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Liofilchem S.r.l., Lumed, Luminex Corporation, Merck & Co., Inc., Novo Holdings A/S, OpGen, Inc., Pfizer Inc., QIAGEN GmbH, Sanofi S.A., Thermo Fisher Scientific Inc., Venatorx Pharmaceuticals, Inc., Viatris Inc., Vivli Inc., and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Resistance Surveillance Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Component
  • Diagnostic Kits
  • Diagnostic Systems
  • Services
  • Software

• End-User
  • Hospitals
  • Research & Academic Institutes

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antimicrobial Resistance Surveillance Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antimicrobial Resistance Surveillance Market?

3. What are the technology trends and regulatory frameworks in the Antimicrobial Resistance Surveillance Market?

4. What is the market share of the leading vendors in the Antimicrobial Resistance Surveillance Market?

5. Which modes and strategic moves are suitable for entering the Antimicrobial Resistance Surveillance Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of infections caused by pathogens
    • 5.1.1.2. Rising government initiatives to improve the quality of diagnostics and point-of-care diagnosis
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with antimicrobial resistance surveillance
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing demand for advanced diagnostic solutions to manage Antimicrobial Resistance (AMR) infections
    • 5.1.3.2. Increasing regulatory approvals of diagnostics products worldwide
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardized methods and guidelines for AMR surveillance
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Significant role of diagnostic kits in offering rapid detection of specific resistance markers at relatively lower costs
  • 5.2.2. End-User: Increasing incidence of hospital-acquired infections developed necessities for next generation antimicrobial resistance (AMR) surveillance
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Antimicrobial Resistance Surveillance Market, by Component

• 6.1. Introduction
• 6.2. Diagnostic Kits
• 6.3. Diagnostic Systems
• 6.4. Services
• 6.5. Software

7. Antimicrobial Resistance Surveillance Market, by End-User

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Research & Academic Institutes

8. Americas Antimicrobial Resistance Surveillance Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Antimicrobial Resistance Surveillance Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Antimicrobial Resistance Surveillance Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Novo Holdings advances antimicrobial resistance strategy with acquisition of Paratek Pharmaceuticals
  • 11.3.2. AMR Action Fund announces more investments to combat antibiotic resistance
• 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

• 12.1. Key Company Profiles
• 12.2. Key Product Portfolio